Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$18.08 USD
+1.22 (7.21%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $19.53 +1.46 (8.05%) 7:24 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.38 | 0.00% |
Earnings Summary
For their last quarter, Edgewise Therapeutics (EWTX) reported earnings of -$0.34 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 5.56%. Look out for EWTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year increase of 7.32%.
Earnings History
Price & Consensus
Zacks News for EWTX
Wall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Know
EWTX: What are Zacks experts saying now?
Zacks Private Portfolio Services